University of Maryland Comprehensive Cancer Center — Baltimore, Maryland

University of Maryland Comprehensive Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Maryland Comprehensive Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Pancreas Adenocarcinoma, Advanced or Unresectable Melanoma Progressing After PD1 Blockade.

Sponsors: NovoCure Ltd., Targovax Oy.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland Comprehensive Cancer Center?

University of Maryland Comprehensive Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland Comprehensive Cancer Center conducted?

University of Maryland Comprehensive Cancer Center has 2 clinical trials on record. Their work covers Pancreas Adenocarcinoma, Advanced or Unresectable Melanoma Progressing After PD1 Blockade.

Is University of Maryland Comprehensive Cancer Center accredited by Crixeo Health?

University of Maryland Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Maryland Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.